OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-Derived Glioma Models: From Patients to Dish to Animals
Cintia Carla da Hora, Markus Schweiger, Thomas Würdinger, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1177-1177
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
Wenxin Zeng, Zhaohua Tang, Yongguo Li, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 154

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies
Alexander F. Haddad, Jacob S. Young, Dominic Amara, et al.
Neuro-Oncology Advances (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 129

Dynamical Analysis of Generalized Tumor Model with Caputo Fractional-Order Derivative
Ausif Padder, Laila Almutairi, Sania Qureshi, et al.
Fractal and Fractional (2023) Vol. 7, Iss. 3, pp. 258-258
Open Access | Times Cited: 70

TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
Jianxiong Ji, Kaikai Ding, Tao Luo, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 1, pp. 367-381
Open Access | Times Cited: 115

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
Christina Piperi, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Cells (2019) Vol. 8, Iss. 11, pp. 1398-1398
Open Access | Times Cited: 94

Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments
Ricardo Gómez‐Oliva, Samuel Domínguez‐García, Livia Carrascal, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 85

The Application of Brain Organoids: From Neuronal Development to Neurological Diseases
Yikai Shou, Feng Liang, Shunliang Xu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 80

First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma
Patrick Y. Wen, Timothy F. Cloughesy, Alan G. Olivero, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 8, pp. 1820-1828
Open Access | Times Cited: 75

A Fractional Modeling of Tumor–Immune System Interaction Related to Lung Cancer with Real Data
Fatma Özköse, Seçil Yılmaz, Mehmet Yavuz, et al.
The European Physical Journal Plus (2021) Vol. 137, Iss. 1
Open Access | Times Cited: 69

Establishment of patient-derived organoid models of lower-grade glioma
Kalil G. Abdullah, Cylaina Bird, Joseph Buehler, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 4, pp. 612-623
Open Access | Times Cited: 67

Organoid Models of Glioblastoma and Their Role in Drug Discovery
Matthew J. Rybin, Michael E. Ivan, Nagi G. Ayad, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 61

Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells
Jiao Wang, Sandra Toregrosa-Allen, Bennett D. Elzey, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 61

Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment
Ruoning Wang, Qifan Liang, Xinru Zhang, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 215, pp. 112505-112505
Closed Access | Times Cited: 45

Organoid models of glioblastoma: advances, applications and challenges.
Chaocai Zhang, Ming-Zhu Jin, Jiannong Zhao, et al.
PubMed (2020) Vol. 10, Iss. 8, pp. 2242-2257
Closed Access | Times Cited: 59

In Vitro Glioblastoma Models: A Journey into the Third Dimension
Mayra Paolillo, Sergio Comincini, Sergio Schinelli
Cancers (2021) Vol. 13, Iss. 10, pp. 2449-2449
Open Access | Times Cited: 52

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges
Cristina Birzu, Suzanne Tran, Franck Bielle, et al.
The Oncologist (2020) Vol. 25, Iss. 11, pp. e1763-e1776
Open Access | Times Cited: 51

Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions
Xavi Solé‐Martí, Albert Espona‐Noguera, Maria‐Pau Ginebra, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 452-452
Open Access | Times Cited: 42

Contemporary Mouse Models in Glioma Research
William H. Hicks, Cylaina Bird, Jeffrey I. Traylor, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 712-712
Open Access | Times Cited: 42

Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Ethan Chen, Alexander Ling, David A. Reardon, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 2, pp. 211-225
Open Access | Times Cited: 17

iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas
Xiaowei Shi, Rui Ma, Yanping Lu, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 527, Iss. 1, pp. 117-123
Closed Access | Times Cited: 41

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
Julie Bolcaen, Janke Kleynhans, Shankari Nair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 7911-7947
Open Access | Times Cited: 39

Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas
Shiyou Wei, Delong Yin, Shengnan Yu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2180-2195
Open Access | Times Cited: 23

Development of a 3D Tumor Spheroid Model from the Patient’s Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging
D V Yuzhakova, Maria M. Lukina, D A Sachkova, et al.
Sovremennye tehnologii v medicine (2023) Vol. 15, Iss. 2, pp. 28-28
Open Access | Times Cited: 16

Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts
Elin Almstedt, Emil Rosén, Marleen Gloger, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 726-738
Open Access | Times Cited: 31

Page 1 - Next Page

Scroll to top